Copy of `SWI - Cancer info`
The wordlist doesn't exist anymore, or, the website doesn't exist anymore. On this page you can find a copy of the original information. The information may have been taken offline because it is outdated.
|
|
SWI - Cancer info
Category: Health and Medicine > Bones
Date & country: 25/03/2011, USA Words: 95
|
AblationIn medicine, the removal or destruction of a body part or tissue or its function. Ablation may be performed by surgery, hormones, drugs, radiofrequency, heat, or other methods.
AdjunctIn cancer therapy, a drug or substance used in addition to the primary therapy.
AnalgesicA drug that reduces pain. Analgesics include aspirin, acetaminophen, and ibuprofen.
analysisAndersen-Gill multiple event analysis considers all skeletal-related events and the time between events to provide a hazard ratio that expresses the risk of an event developing (Source Rosen LS. Cancer. 2003;981735-1744).
AndrogenA type of hormone that promotes the development and maintenance of male sex characteristics.
AntiandrogenAny substance capable of inhibiting the biologic effects of androgen.
AromataseAn enzyme that helps convert the male hormone testosterone to the aromatic compound estradiol, a female hormone.
AutophosphorylationAddition of a phosphate to a protein kinase (possibly affecting its activity) by virtue of its own enzymatic activity.
BisphosphonateA type of drug used to treat osteoporosis and the bone pain caused by some types of cancer.
Bone scanA technique to create images of bones on a computer screen or on film. A small amount of radioactive material is injected into a blood vessel and travels through the bloodstream; it collects in the bones and is detected by a scanner.
CapillariesExtremely small blood vessels.
complicationsEvents, including pathologic fracture and spinal cord compression, that require interventions such as radiation to bone or surgery to bone. Sometimes hypocalcemia of malignancy is included. Also called skeletal-related events.
CytokinesNonantibody proteins released by a group of cells when stimulated by a specific antigen, which act as intercellular mediators.
Cytotoxic therapyA treatment that may be destructive to certain cells.
density (BMD)A measure of bone strength.
DEXADual x-ray absorptiometry; a 2-dimensional measure of bone density.
endpointThe main result that is measured at the end of a study to see if a given treatment worked (eg, the number of deaths or the difference in survival between the treatment group and the control group). What the primary endpoint will be is decided before the study begins.
EstrogenA hormone that promotes the development and maintenance of female sex characteristics.
EtiologyThe causes or origins of disease.
events (SREs)Events, including pathologic fracture and spinal cord compression, that require interventions such as radiation to bone or surgery to bone. Sometimes hypocalcemia of malignancy is included. Also called skeletal complications.
factorA cytokine that can cause hemorrhagic death of certain tumor cells in vivo and in vitro but that does not affect normal cells.
failurePremature menopause caused frequently by adjuvant chemotherapy for breast cancer.
Femoral neckPortion of the femur between the femoral head (by the hip) and the shaft of the femur.
FemurThe long bone at the upper part of the leg, extending from the hip to the knee.
GlucocorticoidA compound that belongs to the family of compounds called corticosteroids (steroids). Glucocorticoids affect metabolism and have anti-inflammatory and immunosuppressive effects. They may be naturally produced (hormones) or synthetic (drugs).
GnRH agonistA pharmacologic agent that promotes gonadotropin-releasing hormone activity.
GonadalFrom gonad, which is part of the reproductive system that produces and releases eggs (ovary) or sperm (testicle/testis).
growth factorA growth-hormone-dependent mediator of cell growth with insulinlike actions.
growth factorProteins secreted by transformed cells that can stimulate growth of normal cells.
Growth hormoneA hormone that affects metabolism of proteins, carbohydrates, and lipids and controls the rate of skeletal and visceral growth.
GutAll of part of the alimentary canal, especially the intestines; the belly or stomach.
HematopoieticRelated to the formation and development of blood cells.
HomeostasisThe tendency of an organism toward stability in the normal body states.
HumorallyRefers to that which is dissolved in blood and other body fluids.
HypertoniaThe excessive tone of skeletal muscles and the muscles' resistance to stretching.
HypogonadismA condition resulting from or characterized by abnormally decreased functional activity of the gonads.
Hyponephrosis((Faculty please provide a definition))
imaging (MRI)A procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. These pictures can show the difference between normal and diseased tissue. MRI makes better images of organs and soft tissue than do other scanning techniques, such as CT or x-ray. It is especially useful for imaging the brain, spine, the soft tissue of joints,...
imbalanced boneIn bone remodeling that is uncoupled and imbalanced, there is an excessive amount of newly woven weak bone that is easily fractured. Osteoblastic activity becomes abnormal such that there may be a net increase in bone formation at sites with no previous bone resorption. Commonly seen in osteoblastic lesions in patients with prostate cancer metastases.
IncidenceThe number of newly diagnosed cases during a specific time period.
InfusionA method of putting fluids, including drugs, into the bloodstream. Also called intravenous infusion.
inhibitorA drug that interferes with aromatase to prevent the conversion of the male hormone testosterone to the female hormone estradiol. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Interleukin-1A cytokine that mediates the body's inflammatory response.
InterleukinsMultifunctional cytokines whose effects are at least partly within the lymphopoietic system.
junctionThe point at which the ureter and bladder connect.
LesionAn area of abnormal tissue. A lesion may be benign (noncancerous) or malignant (cancerous).
lesionDestruction of bone due to a disease process, usually cancer.
LHRH agonistA pharmacologic agent that promotes luteinizing hormone-releasing hormone activity.
loss (CTIBL)Loss of bone mass as a result of specific cancer treatments
Lumbar spineA part of the back between the chest and the pelvis.
LyticPertaining to lysis, destruction of cells. In biology, lysis refers to the disintegration of a cell by disruption of its plasma membrane. Also pertains to destruction of an area of bone due to a disease process, such as cancer.
Lytic lesionDestruction of an area of bone due to a disease process, such as cancer.
MalignantCancerous. Malignant tumors can invade and destroy nearby tissue and spread (metastasize) to other parts of the body.
markerAn entity, test, or measure used to substitute for another measure, for example, biochemical bone markers as a surrogate marker of bone loss or formation.
MetastasisThe spread of cancer from one part of the body to another. A tumor formed by cells that have spread is called a "metastatic tumor" or a "metastasis." The metastatic tumor contains cells that are like those in the original (primary) tumor.
MetastaticHaving to do with metastasis, which is the spread of cancer from one part of the body to another.
MGUSMonoclonal gammopathy of undetermined significance, showing an M-protein in the serum without symptoms or findings of multiple myeloma, macroglobulinemia, amyloidosis, or lymphoma and with fewer than 10% plasma cells in the bone marrow.
modulator (SERM)A drug that acts like estrogen on some tissues but blocks the effect of estrogen on other tissues. Tamoxifen and raloxifene are SERMs.
MorbidityA disease or the incidence of disease within a population. Morbidity also refers to adverse effects caused by a treatment.
NeoplasmAny new abnormal growth of cells that is uncontrolled and progressive.
of malignancyAbnormally high blood calcium levels, resulting from cancer.
OophorectomyRemoval of an ovary or ovaries (bilateral); also called ovariectomy.
OrchiectomyExcision of one or both testes; if both, also called castration.
OsteoblastA cell that forms bone in the bone remodeling process.
OsteoclastA cell that resorbs bone into the body in the bone remodeling process.
OsteoclastogenesisFormation of osteoclasts (bones cells)
OsteolysisDestruction of bone.
OsteopeniaReduced bone mass due to a decrease in the rate of osteoid (bone) synthesis or production to a level insufficient to compensate for normal bone lysis (destruction). The term is also used to refer to any decrease in bone mass below normal. (Osteopenia T-score = -1 to -2.5)
OsteoporosisA condition that is characterized by a decrease in bone mass and density, causing bones to become fragile and at risk of fracture. (Osteoporosis T-score = ≤-2.5)
P valueA statistics term. A measure of probability that a difference between groups during an experiment happened by chance. For example, a P value of .01 (P=.01) means there is a 1 in 100 chance that the result of an experiment occurred by chance. The lower the P value, the more likely it is that the difference between groups was caused by treatment and not by chance.
Palliative careCare given to improve the quality of life of patients who have a serious or life-threatening disease. The goal of palliative care is to prevent or treat as early as possible the symptoms of the disease, side effects caused by treatment of the disease, and psychological, social, and spiritual problems related to the disease or its treatment. Also called comfort care, supportive care, and symptom ma...
PanocytopeniaDeficiency of all elements of the blood.
Parathyroid hormoneA polypeptide hormone secreted by the parathyroid glands. It activates osteoclasts and inhibits osteoblasts.
Pathologic fractureA broken bone caused by disease, often by the spread of cancer to the bone.
period rateNumber of 12-week periods with new skeletal complications (vertebral and nonvertebral fractures, bone radiotherapy, or bone surgery), divided by the number of periods on the study. (Source Tripathy D et al. Annals Oncol. 2004;15743-750, p744).
PlaceboAn inactive substance or treatment that looks the same as, and is given the same way as, an active drug or treatment being tested. The effects of the active drug or treatment are compared to the effects of the placebo.
Plain radiographPlain x-ray film. Image produced by x-ray imaging.
PrenylationThe covalent addition of prenyl and multiprenyl residues to a macromolecule.
PrevalenceReflects the number of patients with a certain disease in a population at a given time.
RandomizeRandomization. When referring to an experiment or clinical trial, the process by which animal or human subjects are assigned by chance to separate groups that compare different treatments or other interventions. Randomization gives each participant an equal chance of being assigned to any of the groups.
refractoryIn oncology, this term describes cancer that does not respond to hormone treatment. Also known as hormone resistant.
related peptideA substance secreted by certain types of cancer cells that causes hypocalcemia.
releasing hormoneAny hypothalamic factor that stimulates release of both follicle-stimulating hormone and luteinizing hormone.
ResorptionA process by which a substance in the body, such as bone tissue, is lost by being destroyed and then absorbed by the body.
responsiveIn oncology, this term describes cancer that responds to hormone treatment.
Side chainA group of atoms attached to another chain or ring of atoms. It also can be a group of radicals in a chemical compound.
significanceA mathematical measure of the difference between groups. The difference is said to be statistically significant if it is greater than what might be expected to happen by chance alone. (See P value)
Skeletal wellnessAn integrated approach to recognize the impact of cancer and cancer treatment on bone health and to adopt methods to treat and prevent bone complications so as to optimize quality of life.
StromalFrom stroma, which is the connective tissue forming the framework or matrix of an organ.
studyA study that compares two groups of people those with the disease or condition under study (cases) and a very similar group of people who do not have the disease or condition (controls). Researchers study the medical and lifestyle histories of the people in each group to learn what factors may be associated with the disease or condition. For example, one group may have been exposed to a particular...
Supportive careSee palliative care.
T-scoreBone mineral density (BMD) measurement is commonly reported in terms of a T-score, which is measured against the bone mineral density of a reference population of young healthy adult women. The T-score is also used to define osteoporosis and osteopenia.
TetanyHyperexcitability of nerves and muscles caused by a decrease in the concentration of extracellular calcium.
therapy (ADT)Hormone therapy to lower levels of the male hormones (androgens) in the body.
UreterThe fibromuscular tube that carries urine from the kidney to the bladder.